SEC Form D · Amendment · filed July 18, 2017
Insilico Medicine, Inc
Offering
$2.8M
Sold
$2.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BALTIMORE, MD
Type
—
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (2)
Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗